Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_431309bc8dab94a0ee0e2aa5aeacd48d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 |
filingDate |
2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03b6499f1e8bb16caef7c54453092349 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d65bba60c95a8906374385d839290ed7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7feda65ced8ef6f1e027acee4fab0412 |
publicationDate |
2022-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022240810-A1 |
titleOfInvention |
Pharmaceutical composition for use in treating cerebral infarction |
abstract |
To provide a safe and effective therapy and pharmaceutical composition using SMTP-7 (Compound I) or a salt thereof in cerebral infarction patients. A pharmaceutical composition for treating cerebral infarction, comprising SMTP-7 (Compound I) or a pharmacological acceptable salt thereof, which is administered at a dose of 1 to 6 mg/kg as SMTP-7 (Compound I) or a salt thereof. |
priorityDate |
2021-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |